Market News & Trends
RoundTable Healthcare Acquires DPT Laboratories
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, recently announced that its portfolio company, Renaissance Acquisition Holdings, LLC has…
Starpharma Reports Rapid Advancement of Delivery Program
Starpharma Holdings Ltd recently provided an update on the developments within its substantial drug delivery program. Starpharma's program to enhance the blockbuster cancer drug docetaxel…
6/27/2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted to $180 million, the sixth…
Ambrx & Merck to Design & Develop Biologic Drug Conjugates
Ambrx recently announced the company has entered into a collaboration with Merck to design and develop rationally optimized biologic drug conjugates based on Ambrx's site-specific…
AmDerma & Oculus Enter Multi-Country Agreement
AmDerma Pharmaceuticals, LLC, a privately owned company (and parent company of Quinnova Pharmaceuticals, Inc.) and Oculus Innovative Sciences recently announced the execution of an agreement…
Catalent & Bend Research Form Strategic Partnership
Catalent Pharma Solutions, Inc. and Bend Research Inc. recently announced they have entered into an agreement to provide integrated solutions for pharmaceutical companies seeking to…
Hovione Reports Significant Sales Growth
Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted to $180 million, the sixth consecutive year of sales growth,…
Idenix Announces Positive Clinical Data
Idenix Pharmaceuticals, Inc. recently announced results from an ongoing Phase IIb study of IDX184 in combination with pegylated interferon and ribavirin (PegIFN/RBV). Of the first…
MicroDose Therapeutx & Moerae Matrix Announce Collaboration
MicroDose Therapeutx, Inc. and Moerae Matrix, Inc. recently announced they have signed a collaboration agreement to develop a dry powder inhalation product of Moerae's novel…
Astex Earns $5.4-Million Milestone
Astex Pharmaceuticals, Inc. recently announced that Janssen Pharmaceutica NV has received clearance to commence a Phase I clinical trial of a Fibroblast Growth Factor Receptor…
Cook Pharmica Receives Milestone FDA Approval
Cook Pharmica LLC recently announced it has received its first approval from the US FDA to manufacture commercial product. The product approval for commercial manufacturing…
D3 Pharma & Encap Drug Delivery Continue Partnership
D3 Pharma Limited recently announced its continuing partnership with Encap Drug Delivery to expedite the commercial manufacturing and product licensing program for its proprietary high-dose…
KineMed Announces Biomarker Discovery Collaboration With Major Pharma Co.
KineMed, Inc. recently announced a multi-year R&D collaboration with GlaxoSmithKline plc (GSK) that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest…
NTA Used to Characterize Microvesicles as Potential Biomarkers
NanoSight recently reported on the work of Professor Hang (Hubert) Yin's group at the University of Colorado at Boulder in which they apply Nanoparticle Tracking…
XTL Biopharmaceuticals to Acquire Kitov for Up to $48 Million
XTL Biopharmaceuticals Ltd. recently announced it will acquire Kitov Pharmaceuticals Ltd. in consideration for shares as well as cash milestone payments throughout Kitov's development and…
6/20/2012
Astex Earns $5.4-Million Milestone Astex Pharmaceuticals, Inc. recently announced that Janssen Pharmaceutica NV has received clearance to commence a Phase I clinical trial of a…
6/13/2012
Particle Sciences Expands cGMP Capabilities With Addition of Thin Films Particle Sciences recently announced it has added new coating capabilities for preparing polymer film"based drug…
GSK Successfully Uses Capsugel's Licaps
Capsugel recently announced that its Licaps liquid-filled hard capsules have been successfully used by major healthcare company, GlaxoSmithKline (GSK), for the most established brand in…
Particle Sciences Expands cGMP Capabilities With Addition of Thin Films
Particle Sciences recently announced it has added new coating capabilities for preparing polymer film"based drug products from liquid formulations, under cGMPs. According to Garry Gwozdz,…
Protalix Biotherapeutics Gets $25-Million Milestone Payment
Protalix BioTherapeutics, Inc. recently announced it has received a $25-million milestone payment from Pfizer Inc. as part of the companies' global commercial agreement for ELELYSO…
